{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:57:50Z","timestamp":1773712670571,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.yebeh.2008.04.021","type":"journal-article","created":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T12:24:08Z","timestamp":1213359848000},"page":"397-401","source":"Crossref","is-referenced-by-count":20,"title":["Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability"],"prefix":"10.1016","volume":"13","author":[{"given":"Bernd","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelina","family":"Bocchicchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Feuerbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodor","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Meinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heide","family":"Schorlemmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Wilking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2008.04.021_bib1","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","article-title":"Dose\u2013response trial of pregabalin adjunctive therapy in patients with partial seizures","volume":"60","author":"French","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2008.04.021_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","article-title":"Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose\u2013response study in adults with partial seizures","volume":"45","author":"Arroyo","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.04.021_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/01.WNL.0000150932.48688.BE","article-title":"Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy","volume":"64","author":"Beydoun","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2008.04.021_bib4","first-page":"638","article-title":"Leitlinien zur Durchf\u00fchrung von Anwendungsbeobachtungen in der Psychopharmakatherapie","volume":"65","author":"Linden","year":"1994","journal-title":"Der Nervenarzt"},{"key":"10.1016\/j.yebeh.2008.04.021_bib5","unstructured":"Association for Methodology and Documentation in Psychiatry (AMDP), Collegium Internationale Psychiatriae Scalarum (CIPS). Rating scales for psychiatry. European ed. Weinheim: Beltz Test GmbH; 1990."},{"key":"10.1016\/j.yebeh.2008.04.021_bib6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1528-1157.2001.10401.x","article-title":"A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology","volume":"42","author":"Engel","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.04.021_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.seizure.2007.05.011","article-title":"Pregabalin as add-on therapy for refractory partial seizures in everyday clinical practice","volume":"16","author":"Carre\u0148o","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2008.04.021_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.yebeh.2006.12.005","article-title":"Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability","volume":"10","author":"Simister","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.04.021_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00044011-199816040-00001","article-title":"Lamotrigine in multihandicapped therapy-resistant epileptic patients","volume":"16","author":"Huber","year":"1998","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.yebeh.2008.04.021_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00115-002-1294-3","article-title":"[Effects of topiramate in patients with epilepsy and intellectual deficits]","volume":"73","author":"Huber","year":"2002","journal-title":"Nervenarzt"},{"key":"10.1016\/j.yebeh.2008.04.021_bib11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1059-1311(03)00101-8","article-title":"Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients","volume":"12","author":"Huber","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2008.04.021_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1059-1311(03)00154-7","article-title":"Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities","volume":"13","author":"Huber","year":"2004","journal-title":"Seizure"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505008001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505008001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T17:21:10Z","timestamp":1545931270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505008001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1525505008001030"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2008.04.021","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}